Research Groups and R&D Platforms: Biomarker
Research Group:
Tissues Regeneration and Cancer
Fang Cheng
fang.cheng[at]utu.fi
Turku Bioscience Centre,
University of Turku
Assay development, Biomarker, Biomedicine, Biotechnology, Cancer, Colorectal cancer, Disease models, Drug target, High throughput imaging, Imaging, Inflammation, Lead optimization, Metabolic diseases, Molecular Cell Biology, Natural Compounds, Personalized medicine, Screening, Signaling, Skin diseases, Target discovery
Research Group:
Signaling of Receptor Tyrosine Kinases in Cancer and Development
Klaus Elenius
klaele[at]utu.fi
Institute of Biomedicine,
University of Turku
Basic research, Biomarker, Biomedicine, Breast cancer, Cancer, Colorectal cancer, Data mining, Diagnostics, Drug delivery, Drug target, Genomics, Lung cancer, Melanoma, Molecular Cell Biology, Molecular modelling, Next-generation sequencing, Pathology, Personalized medicine, Receptor, Signaling, Squamous cell carcinoma, Target discovery
Research Group:
Bone and energy metabolism
Kaisa Ivaska
kaisa.ivaska[at]utu.fi
Institute of Biomedicine,
University of Turku
Ageing-related diseases, Assay development, Basic research, Biomarker, Biomedicine, Diabetes, In Vitro Diagnostics, Metabolic diseases, Molecular Cell Biology, Musculoskeletal disorders, Obesity
Research Group:
Traumatic Brain Injury Research Group / Neurosurgical Implant Group
Jussi Posti / Olli Tenovuo
jussi.posti[at]utu.fi
Turku University Hospital,
University of Turku
Biomarker, Biomedicine, Clinical Chemistry, Clinical Medicine, Diagnostics, Drug target, Genetics, Genomics, Imaging, Imaging software, In Vivo Diagnostics, Metabolomics, Personalized medicine, Point of care, Proteomics, Surface area, Systems Biology
Research Group:
Neuronal Signalling Pathways
Michael Courtney
miccou[at]utu.fi
Neuronal Signalling Laboratory
Turku Bioscience Centre,
University of Turku
Ageing-related diseases, Assay development, Basic research, Biochemistry, Biomarker, Biomedicine, Biotechnology, Cancer, Data mining, Disease models, Drug delivery, Drug target, Fluorescence spectroscopy, High throughput imaging, Hit to lead, Imaging, Imaging software, In Vitro Diagnostics, Molecular Biology, Molecular Cell Biology, Molecular modelling, Natural Compounds, Natural products, Neurological disorders, Organic compounds, Pharmacology, Screening, Signaling, Synthetic Biology, Target discovery
Research Group:
Molecular Systems Immunology
Riitta Lahesmaa
Contact person: Anne Lahdenperä, anne.lahdenpera[at]bioscience.fi
Molecular Immunology Group,
Turku Bioscience Centre,
University of Turku
Allergy, Asthma, Autoimmune diseases, Basic research, Bioinformatics, Biomarker, Biomedicine, Biotechnology, Cancer, Cardiovascular diseases, Data mining, Diabetes, Diagnostics, Epigenomics, Genomics, Immunology, In Vitro Diagnostics, Infection, Inflammation, Metabolic diseases, Molecular Biology, Molecular Cell Biology, Next-generation sequencing, Personalized medicine, Proteomics, Receptor, Signaling, Systems Biology, Target discovery
